ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2021 and some content may be unavailable. To unlock all content for 2021, please visit the archives.

Abstract: PO1432

Gut Microbiome Changes in NZBWF1/J Murine Lupus Nephritis

Session Information

Category: Glomerular Diseases

  • 1201 Glomerular Diseases: Fibrosis and Extracellular Matrix

Authors

  • Chan, Tak Mao Daniel, Department of Medicine, the University of Hong Kong, Hong Kong, Hong Kong
  • Yu, Jing, Department of Medicine, the University of Hong Kong, Hong Kong, Hong Kong
  • Tai, Chi pang, Department of Medicine, the University of Hong Kong, Hong Kong, Hong Kong
  • Yung, Susan, Department of Medicine, the University of Hong Kong, Hong Kong, Hong Kong
Background

Lupus nephritis is an important cause of acute kidney injury and chronic kidney disease. There is preliminary data that gut dysbiosis may be involved in the pathogenesis of lupus nephritis. We investigated gut microbiota burden in murine lupus nephritis.

Methods

Eight-week old NZBWF1/J mice were randomized to receive drinking water alone or containing ampicillin (1.0 mg/ml) and neomycin (0.5 mg/ml) for 18 weeks. Renal and colonic histopathology was examined, and intestinal mucosal permeability investigated with LPS-FITC. Quantitative changes in gut microbiota were assessed by 16S rRNA sequencing.

Results

Serum LPS and urea levels, and proteinuria were significantly lower in antibiotic-treated mice (P<0.05, for all). Histopathologic manifestation of active nephritis and podocyte foot process effacement were associated with increased LPS-binding protein, CD14 and TLR-4 expression in proximal renal tubular epithelial cells, and increased interstitial α-smooth muscle actin, fibronectin and collagen expression. Mice with active nephritis showed increased gut permeability to LPS-FITC given orally, and decreased ZO-1 expression in the colonic epithelium. 16S rRNA sequencing data showed that active nephritis was associated with a progressive decrease in Gram-positive bacteria phyla Actinobacteria and Firmicutes and increased Gram-negative bacteria phyla Bacteroides and Proteobacteria. Antibiotic treatment significantly decreased Bacteroides, which was associated with lower levels of serum LPS and urea, proteinuria, and ameliorated histopathologic features in the colon and kidney.

Conclusion

Murine lupus nephritis is associated with gut dysbiosis, which may contribute to the pathogenesis of nephritis progression.

Funding

  • Government Support – Non-U.S.